Xiaohong Xu

541 citations
27 papers · 268 indexed · h-index 9
Topics
Cancer-related molecular mechanisms research (4 papers)HER2/EGFR in Cancer Research (3 papers)Estrogen and related hormone effects (3 papers)
Partner nations
ChinaUnited StatesIndia

In The Last Decade

Xiaohong Xu

22 papers receiving 266 citations

Peers

Xiaohong Xu
Comparison fields: 5 of 65
  • Molecular Biology 121
  • Oncology 73
  • Cancer Research 72
  • Pulmonary and Respiratory Medicine 59
  • Radiology, Nuclear Medicine and Imaging 35
Replace Bok‐Soon Lee with:
Bok‐Soon Lee South Korea
Chunbao Zang China
Fubo Zhou China
Xiaohua Wu China
Chun Chen China
Anusha Thadi United States
Alice E. Shin United States
Jian Chu China
Benno Traub Germany
Lyndsay Willmott United States
Xiaohong Xu relative to Bok‐Soon Lee South Korea Bok‐Soon Lee's profile →
Citations per field
00.5×1.6×
Bok‐Soon Lee · 1×
Citations per year

Countries citing papers authored by Xiaohong Xu

Since Specialization
Citations

This map shows the geographic impact of Xiaohong Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaohong Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaohong Xu more than expected).

Fields of papers citing papers by Xiaohong Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaohong Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaohong Xu. The network helps show where Xiaohong Xu may publish in the future.

Co-authorship network of co-authors of Xiaohong Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaohong Xu. A scholar is included among the top collaborators of Xiaohong Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaohong Xu. Xiaohong Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 0
4 4
5 2
6 2
7 0
8 5
9 1
10 25
11 48
12 5
13 4
14 13
15 5
16 2
17 12
18 11
19 17
20
[Dynamic observation of the features of chest radiograph in SARS patients].
2

About Xiaohong Xu

Xiaohong Xu is a scholar working on Cancer Research, Oncology and Neurology, having authored 27 papers that have together received 268 indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (4 papers), HER2/EGFR in Cancer Research (3 papers) and Estrogen and related hormone effects (3 papers). The work is most often cited by research in Cancer Research (72 citations), Oncology (73 citations) and Molecular Medicine (9 citations). Xiaohong Xu has collaborated with scholars based in China, United States and India. Frequent co-authors include Yongyi Chen, Yimin Zhang, Xiaopeng Liu, Xuejun Hu, Shucai Zhang, Shengxiang Ren, Jing Zhou, Tao Jiang, Yan Li and Yayi He. Their work appears in journals such as Nature Communications, Journal of Clinical Oncology and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026